Zealand Pharma — Marts 2022
-
Den falder vel ikke 13% ved at nogle lukker deres short
-
Enig Exit - resultaterne de kommende 6 måneder, men det står sløjt til med kapitalen. Emission er no go i nuværende kurs og lånefinaniseret drift, er en dårlig spiral, at have i
. -
@DeltaFlyver - måske
Du tror jo også, at markedet reagerer med 18 timers forsinkelse, så hvem ved 
-
@DeltaFlyer - ikke mange shorts de lukkes lige nu (lav omsætning) men de kan lige så godt få statet op på det umulige projekt.
-
Nordea gentager sin købsanbefaling med kursmål 234 i dag: Zealand Pharma (Zealand) reported overall 2021 numbers in line with expectations but with Zegalogue sales of DKK 5.5m continuing to miss estimates. For 2022, Zealand is guiding for product sales of DKK 235m, +/-10%, which was also below our expectations. We once again cut our Zegalogue estimates to reflect a slower than expected uptake curve and our DCF-derived target price is lowered to DKK 234 (254). We remain buyers of the stock as we
-
(...) continue to believe that Zealand is undervalued based on its late-stage pipeline, but we acknowledge that the stock will likely remain depressed and range-bound until its high-impact pipeline data materialises – in particular the ph III glepaglutide data in SBS during Q3 2022
-
@Cubinvest2021 - tak!
-
Så er vi tilbage i samme kurs som for 4 år siden... SUK
-
De professionelle shortere kan sagtens presse kursen ned for at aktivere stop loss og købe i bunden, men det her ligner mere øgede shortpositioner
-
"Needham & Company Reiterates Zealand Pharma (ZEAL) at Buy, Short Bowel Syndrome Program Remains Main Value Driver"
"Needham & Company analyst Joseph Stringer reiterated a Buy rating and $42.00 price target on Zealand Pharma A/S (NASDAQ: ZEAL) .."Svarer til kurs DKK 284,-
-
Zealand Pharma/Nordea: Sænker kursmål med en tyver https://proinvestor.com/investornyt/794047/zealand-pharma-nordea-saenker-kursmal-med-en-tyver
-
Zealand Pharma/Danske: Sænker kursmål til 250 kr. fra 285 kr. https://proinvestor.com/investornyt/794062/zealand-pharma-danske-saenker-kursmal-til-250-kr-fra-285-kr
-
Har også suppleret - når man ser de off mægleres target på ca 200 og kun små ned justeringer virker faldet stort?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind